Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Kevin Outterson; Unni Gopinathan; Charles Clift; Anthony D. So; Chantal M. Morel; John Arne Røttingen

doi:10.1371/journal.pmed.1002043

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Kevin Outterson, Unni Gopinathan, Charles Clift, Anthony D. So, Chantal M. Morel, John Arne Røttingen

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Original language	English (US)
Article number	e1002043
Journal	PLoS medicine
Volume	13
Issue number	6
DOIs	https://doi.org/10.1371/journal.pmed.1002043
State	Published - Jun 2016

ASJC Scopus subject areas

General Medicine

Access to Document

10.1371/journal.pmed.1002043

Cite this

@article{f2f270c7470e4036b72b9a36f255ed24,

title = "Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality",

author = "Kevin Outterson and Unni Gopinathan and Charles Clift and So, {Anthony D.} and Morel, {Chantal M.} and R{\o}ttingen, {John Arne}",

note = "Funding Information: AS's work on antibiotic resistance is supported both by a Swedish Sida grant for ReAct—Action on Antibiotic Resistance and as a recipient of the Robert Wood Johnson Investigator Award in Health Policy Research. CC is Chair of the Governing Board of the Medicines Patent Pool. The remaining authors have declared that no competing interests exist. ",

year = "2016",

month = jun,

doi = "10.1371/journal.pmed.1002043",

language = "English (US)",

volume = "13",

journal = "PLoS medicine",

issn = "1549-1277",

number = "6",

}

TY - JOUR

T1 - Delinking Investment in Antibiotic Research and Development from Sales Revenues

T2 - The Challenges of Transforming a Promising Idea into Reality

AU - Outterson, Kevin

AU - Gopinathan, Unni

AU - Clift, Charles

AU - So, Anthony D.

AU - Morel, Chantal M.

AU - Røttingen, John Arne

N1 - Funding Information: AS's work on antibiotic resistance is supported both by a Swedish Sida grant for ReAct—Action on Antibiotic Resistance and as a recipient of the Robert Wood Johnson Investigator Award in Health Policy Research. CC is Chair of the Governing Board of the Medicines Patent Pool. The remaining authors have declared that no competing interests exist.

PY - 2016/6

Y1 - 2016/6

UR - http://www.scopus.com/inward/record.url?scp=84978032252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978032252&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1002043

DO - 10.1371/journal.pmed.1002043

M3 - Article

C2 - 27299990

AN - SCOPUS:84978032252

SN - 1549-1277

VL - 13

JO - PLoS medicine

JF - PLoS medicine

IS - 6

M1 - e1002043

ER -

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this